UCB provides solutions that are inspired by patients and driven by science

Important note

For patients: If you believe you are experiencing an adverse event to a UCB Product, please contact your healthcare professional. If you have a medical enquiry, or wish to report an adverse event or product quality complaint, please contact UCB via email ucbcares.au@ucb.com or phone 03 9828 1800 (select option 3).

For healthcare professionals: If you have a medical enquiry, or wish to report an adverse event or product quality complaint, please contact UCB via email ucbcares.au@ucb.com or phone 03 9828 1800 (select option 3).

NEUPRO® is a registered trademark of UCB Pharma GmbH. VIMPAT® is a registered trademark used by UCB Pharma GmbH under license. FINTEPLA® is a registered trademark of the UCB Group of Companies. BIMZELX®,  BRIVIACT®, CIMZIA®, KEPPRA®, RYSTIGGO® and ZILBRYSQ® are registered trademarks of UCB Biopharma SRL.

AU-OT-2400032. May 2025.